title: Effect of isradipine on endothelin-1 plasma concentrations in patients with Raynaud's phenomenon.
authors.forename: L
authors.initials: L
authors.lastname: La Civita
authors.forename: D
authors.initials: D
authors.lastname: Giuggioli
authors.forename: M G
authors.initials: MG
authors.lastname: Del Chicca
authors.forename: G
authors.initials: G
authors.lastname: Longombardo
authors.forename: G
authors.initials: G
authors.lastname: Pasero
authors.forename: C
authors.initials: C
authors.lastname: Ferri
mesh_terms: D000328:Adult; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004311:Double-Blind Method; D016232:Endothelins / Q000097:blood*; D005260:Female; D006801:Humans; D017275:Isradipine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011928:Raynaud Disease / Q000097:blood* / Q000188:drug therapy; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D002121:Calcium Channel Blockers; D016232:Endothelins; D014665:Vasodilator Agents; D017275:Isradipine